All Microbial Biotechnology articles
-
NewsNew cell-sorting platform accelerates discovery of high-value microbes
Researchers have developed an advanced, high-throughput single-cell sorting platform that enables direct isolation of living cells with targeted metabolic profiles from large mutant libraries.
-
NewsBiosynthetic pathway discoveries mean we can halve the price of costly cancer drug
Researchers have identified the enzymes responsible for the two critical final steps in the biosynthetic pathway that makes the chemotherapy drug Taxol active as a drug, potentially opening it up to biotech based production.
-
NewsSilver nanoparticles produced by fungus could be used to prevent and treat COVID-19
Silver nanoparticles produced by the fungus Trichoderma reesei could become important allies in the prevention and treatment of COVID-19. Tests on hamsters showed that they not only inhibited the infection but also reduced the viral load in the lungs.
-
NewsElectricity-generating bacteria may power future innovations
Scientists have discovered how certain bacteria breathe by generating electricity, using a natural process that pushes electrons into their surroundings instead of breathing on oxygen.
-
NewsNew tool for cutting DNA offers promising prospects for biotechnology
Researchers have developed a new genetic tool based on a family of specific enzymes called Ssn that allows targeted cuts to be induced exclusively in single-stranded DNA. They focused on one of these enzymes in the bacterium Neisseria meningitidis.
-
NewsMicrobial landscape in the early operation phase of China space station
Metagenomics, comparative genomics, and microbial culture techniques were employed to conduct an in-depth analysis of the structure, function, dynamic changes, and adaptation mechanisms of microbial communities within the China Space Station.
-
NewsMicroalgae and bacteria team up to convert CO2 into useful products
Most methods of genetically modifying the bacterium Escherichia coli and other microbes to convert carbon dioxide into useful biological products require additional carbon sources. A new study overcomes this limitation by combining the photosynthetic finesse of a single-celled algae with the production capabilities of the bacteria E. coli.
-
FeaturesUnder the microscope: microalgae-based bioremediation
The rapid expansion of the global human population and the increase in industrial and agricultural activities have led to severe environmental contamination. To remedy the situation, green technology has become more prevalent in recent years due to its numerous environmental benefits.
-
NewsAfro-Caribbean Commercial Science Network (ACCSN) named as winner of Dorothy Jones Diversity and Inclusion Achievement Award 2024
The Afro-Caribbean Commercial Science Network (ACCSN), founded by Daniel Similaki, has been named as this year’s winner of the Dorothy Jones Diversity and Inclusion Achievement Award 2024.
-
NewsNew CRISPRs expand upon the original’s abilities
By scouring through a massive bacterial metagenomic databases, researchers have discovered new CRISPR-Cas systems as efficient as the conventional one. One of the candidate system has found with the technological potential to expand its impact in research, biotechnology and medicine.
-
NewsScottish biotech company Lentitek secures £1m funding to advance next generation cancer treatments
Biotech company Lentitek Ltd has secured £700,000 in private funding from Equity Gap, bringing its total investment to £1 million in the last six months. It develops manufacturing technologies for lentiviral vectors, used with CAR-T cell and gene therapies.
-
NewsResearchers reveal key mechanism behind bacterial cancer therapy
A research team has elucidated the mechanism behind bacterial cancer therapy using a genetically engineered bacterial strain.
-
NewsNewly launched Enodia Therapeutics is a biotech company with a new approach for targeted protein degradation
Argobio and the Institut Pasteur have announced the launch of Enodia Therapeutics, a groundbreaking French biotech company dedicated to block and degrade disease-causing proteins for treating cancer, inflammatory diseases and viral infections.
-
NewsScottish bio-tech company secures £3.4m investment
Scottish biotech engineering company uFraction8 has secured £3.4m in new investment following the completion of a funding round led by Foresight Group.
-
NewsBacteria evolved to help neighboring cells after death, new research reveals
A study has shown that a type of E coli bacteria produces an enzyme which breaks the contents of their cells down into nutrients after death. The dead bacteria are therefore offering a banquet of nutrients to the cells that were their neighbours when they were living.
-
NewsScientists recode the genome for programmable synthetic proteins
Synthetic biologists were able to re-write the genetic code of an organism — a novel genomically recoded organism (GRO) with one stop codon — using a cellular platform that they developed enabling the production of new classes of synthetic proteins.
-
NewsFirst success in overcoming gene therapy challenges deploys nanomachines loaded with wine ingredients
Scientists have demonstrated the ability to overcome significant challenges in gene therapy using adeno-associated virus vectors (AAV) by employing a novel smart nanomachine equipped with AAV.
-
FeaturesFrom Earth to space - exploring fungi in extraterrestrial environments
Fungi are incredible organisms in terms of plasticity, resilience, and adaptation. However, they have the potential to both help and hinder us.
-
CareersThe true cost of science
Discover valuable insights from three companies in the microbiology field, and their experience of balancing innovation, investment, and sustainability to drive their success.
-
NewsCARB-X funds Melio to develop rapid diagnostic to detect neonatal sepsis
CARB-X will award biotechnology company Melio US$3.5M to develop and execute a technical feasibility workplan for its culture-free platform designed to identify blood stream infections including neonatal sepsis.